Tissue Therapies

HOME

TECHNOLOGY

INVESTORS

ALLIANCES

COMPANY

CONTACT

INVESTORS

CORP. GOVERNANCE

HOME INVESTORS

INVESTORS ::

REMUNERATION and NOMINATION COMMITTEE CHARTER
Interested parties can download Tissue Therapies' Reummuneration and Nomination Committee Charter.

CORPORATE GOVERNANCE CHARTER
Interested parties can download Tissue Therapies' Corporate Governance Charter.

RISK MANAGEMENT POLICY
Interested parties can download Tissue Therapies' Risk Management Policy.

2011 ASX ANNOUNCEMENTS

30 Sep 2011: VitroGro Sales to Start Second Quarter 2011 [PDF]
10 Aug 2011: Directors Report and Financial Statements [PDF]
10 Aug 2011: Results for Year Ended 30 June 2011 [PDF]
10 Aug 2011: Appendix 4E [PDF]
28 Jul 2011: Appendix 4C - Quarterly Report [PDF]
14 Jul 2011: Strong New Clinical Trial Data [PDF]
21 Jun 2011: Section 708A Cleansing Notice [PDF
21 Jun 2011: Appendix 3B New Issue Announcement G Morris [PDF]
26 May 2011: Appendix 3B New Issue Announcement, Rights Issue [PDF]
03 May 2011: Appendix 3Y Change in Directors Interest [PDF]
29 Apr 2011: Despatch of Rights Issue Prospectus [PDF]
20 Apr 2011: Appendix 4C Quarterly Report [PDF]
15 Apr 2011: Non-renounceable Rights Issue - Lodgement of Prospectus [PDF]
15 Apr 2011: Prospectus [PDF]
15 Apr 2011: Appendix 3B [PDF]
15 Apr 2011: Non-renounceable Rights Issue - Letter to Eligible Shareholders [PDF]
15 Apr 2011: Non-renounceable Rights Issue - Option Holder Participation [PDF]
15 Apr 2011: Non-renounceable Rights Issue - Letter to Ineligible Shareholders [PDF]
15 Apr 2011: Section 708A Cleansing Notice [PDF]
09 Feb 2011: Appendix 4D Half Year Report [PDF]
28 Jan 2011: ASX Share Trading Policy [PDF]
27 Jan 2011: Reply to ASX Query [PDF]
21 Jan 2011: Appendix 4C - Quarterly Report [PDF]

2010 ASX ANNOUNCEMENTS

29 Dec 2010: Tissue Therapies Ltd – Price Query [PDF]
20 Dec 2010: Update on EU Clinical Trial and Commercial Negotiations [PDF]
09 Nov 2010: Reply to ASX Price Query [PDF]
08 Nov 2010: Appendix 3B [PDF]
22 Oct 2010: Appendix 4C Quarterly Report [PDF]
21 Oct 2010: Appendix 3B [PDF]
21 Oct 2010: Appendix 3Y Change of Directors Interest Notice [PDF]
13 Oct 2010: Resolutions Passed at the 2010 Annual General Meeting [PDF]
13 Oct 2010: Interview with Professor Keith Harding [PDF]
13 Oct 2010: CEO AGM Presentation [PDF]
13 Oct 2010: 2010 AGM Chairman’s Address [PDF]
12 Oct 2010: Third VitroGro® Patent Granted in Australia [PDF]
12 Oct 2010: First VitroGro® Patent Allowed in Europe [PDF]
06 Oct 2010: Third VitroGro® Patent Granted in the USA [PDF]
05 Oct 2010: Appointment of Independent Commercialisation Consultant [PDF]
30 Sep 2010: More Excellent VitroGro® Clinical Results [PDF]
13 Sep 2010: Corrected Proxy Form [PDF]
10 Sep 2010: Tissue Therapies Annual Report 2010 [PDF]
10 Sep 2010: Notice of Annual General Meeting 2010 [PDF]
02 Sep 2010: Exceptional VitroGro® Clinical Results Continue [PDF]
11 Aug 2010: Directors Report and Financial Statements [PDF]
11 Aug 2010: Appendix 4E [PDF]
09 Aug 2010: VitroGro® Patent Granted in Japan [PDF]
23 Jul 2010: Appendix 4C Quarterly Report [PDF]
13 July 2010: Excellent Additional VitroGro® Clinical Results & Completion of Commercial Scale Manufacturing [PDF]
17 Jun 2010: More Exceptional Clinical Results for VitroGro® [PDF]
31 May 2010: Interview with Dr. Steve Mercer, CEO & Director [Video]
16 Mar 2010: Investor Newsletter [PDF]
07 Jan 2010: Human Trial of VitroGro®: Prof Keith Harding, Cardiff University [PDF]

2009 ASX ANNOUNCEMENTS

22 Dec 2009: Appendix 3Y Change in Directors Interest Notice [PDF]
15 Dec 2009: Notice of Change of Interests of Substantial Shareholder 2 [PDF]
15 Dec 2009: Notice of Change of Interests of Substantial Shareholder [PDF]
15 Dec 2009: Appendix 3Y Change in Directors Interest Notice 2 [PDF]
15 Dec 2009: Appendix 3Y Change in Directors Interest Notice [PDF]
14 Dec 2009: Change of Share Registry Address [PDF]
11 Dec 2009: Appendix 3B and Cleansing Notice after SPP [PDF]
07 Dec 2009: Share Purchase Plan Closes Oversubscribed [PDF]
27 Nov 2009: Resolutions Passed at 2009 AGM [PDF]
27 Nov 2009: CEO AGM Presentation [PDF]
27 Nov 2009: Chairman’s 2009 AGM Address [PDF]
26 Nov 2009: Second Core VitroGro® Patent Granted in Australia [PDF]
25 Nov 2009: Second VitroGro® Patent Allowed in USA [PDF]
23 Nov 2009: Shareholder Newsletter [PDF]
23 Nov 2009: Excellent VitroGro® Results: Australian Human Trial [PDF]
18 Nov 2009: Outstanding Human Trial Results for VitroGro® [PDF]
29 Oct 2009: Appendix 4C Quarterly Report [PDF]
21 Oct 2009: Notice of Tissue Therapies AGM [PDF]
21 Oct 2009: Share Purchase Plan Letter to Ineligible Share Holders [PDF]
21 Oct 2009: Share Purchase Plan Letter to Option Holders [PDF]
21 Oct 2009: Share Purchase Plan [PDF]
21 Oct 2009: Share Purchase Plan Letter to Shareholders [PDF]
21 Oct 2009: Announcement of Share Purchase Plan [PDF]
19 Oct 2009: Appendix 3B Following Placement [PDF]
19 Oct 2009: s708A(5)(e) Disclosure Notice Issue of Placement Shares [PDF]
19 Oct 2009: Tissue Therapies Successful $5 million Capital Raising [PDF]
15 Oct 2009 : Trading Halt [PDF]
08 Oct 2009: 2009 Annual Report [PDF]
20 Aug 2009: Change of Share Registry Address [PDF]
20 Aug 2009: Appendix 3X Initial Directors Interest [PDF]
04 Aug 2009: Appendix 4E Preliminary Final Report [PDF]
03 Aug 2009: Tissue Therapies Lists on Frankfurt Stock Exchange [PDF]
29 Jul 2009: Appendix 4C Quarterly Report [PDF]
23 Jul 2009: Excellent Preclinical Results for New Formulation VitroGro® & Progressive Human Trial Results [PDF]
10 Jul 2009: Tissue Therapies Wins Smart State Grant for Single Protein VitroGro® [PDF]
01 Jul 2009: More VitroGro® Patents Granted in South Korea and Australia [PDF]
30 Jun 2009: Appointment of Dr Cherrell Hirst as Company Director [PDF]
29 Apr 2009: Results of 2nd Patient in Canadian Clinical Trial [PDF]
29 Apr 2009: Appendix 4C Quarterly Report [PDF]
30 Mar 2009: Notice of Change of Interests of Substantial Shareholder [PDF]
14 Apr 2009: Resignation of Prof David Gardiner as Director [PDF]
19 Mar 2009: Appendix 3B QUT Note Conversion [PDF]
13 Mar 2009: Appoint Mel Bridges Director [PDF]
12 Mar 2009: App3Y Form 604 Options after Rights Issue [PDF]
10 Mar 2009: Further Investment in Tissue Therapies [PDF]
05 Mar 2009: Asia Union Change of Interests Subst. Shareholder Form 604 [PDF]
05 Mar 2009: App 3B & Top 20 [PDF]
04 Mar 2009: Rights Issue Completion [PDF]
27 Feb 2009: App4D Dir Report Indep Dec FINAL [PDF]
13 Feb 2009: Rights Issue Prospectus despatched [PDF]
03 Feb 2009: Supp Prospectus Jan 2009 [PDF]
02 Feb 2009: Notice of Initial Substantial Shareholder [PDF]
02 Feb 2009: 29% Healing of Chronic Ulcer in 6 weeks: 1st Patient in Canadian Trial [PDF]
30 Jan 2009: 2nd South African Patent Granted [PDF]
28 Jan 2009: Appendix 4C Quarterly Report [PDF]
28 Jan 2009: Tissue Therapies Prospectus
28 Jan 2009: Appendix 3B New Issue Announcement [PDF]
28 Jan 2009: Non-Renounceable Rights Issue [PDF]
28 Jan 2009: Non-Renounceable Rights Issue-Option Holder participation [PDF]
28 Jan 2009: Non-Renounceable Rights Issue-Overseas Shareholders [PDF]
19 Jan 2009: Results of VitroGro Venous Ulcer Human Trial [PDF]
13 Jan 2009: US Patent Granted [PDF]
12 Jan 2009: Appendix 3B CEO Options [PDF]
09 Jan 2009: App 3B Issue New Shares [PDF]

2008 ASX ANNOUNCEMENTS

27 Nov 2008: AGM CEO Presentation [PDF]
27 Nov 2008: AGM Chairman's Address [PDF]
27 Nov 2008: AGM Chief Scientist Presentation [PDF]
27 Nov 2008: AGM Resolutions passed with Proxy [PDF]
11 Nov 2008: Clinical Results Patient 3 [PDF]
11 Nov 2008: Clinical Results Patient 4 [PDF]
11 Nov 2008: Health Canada Approval [PDF]
31 Oct 2008: Appendix 4C Quarterly Report [PDF]
27 Oct 2008: 2008 Annual Report [PDF]
27 Oct 2008: Notice of Meeting Proxy Form [PDF]
20 Oct 2008: Results of Second Patient Treated with VitroGro® [PDF]
22 Sep 2008: Change of CEO Interest [PDF]
03 Sep 2008: Results of First Patient Treated with VitroGro® [PDF]
19 Aug 2008: SPP Extended [PDF]
19 Aug 2008: SPP Extended Timetable [PDF]
06 Aug 2008: SPP docs issued to shareholders [PDF]
11 Aug 2008: Perth Human Trials [PDF]
08 Aug 2008: Appendix 4E [PDF]
23 Jul 2008: Correction to Link contact details [PDF]
21 Jul 2008: Share Purchase Plan Rules [PDF]
21 Jul 2008: Letter to Shareholders - Share Purchase Plan [PDF]
21 Jul 2008: Letter to Optionholders [PDF]
21 Jul 2008: Investor Update [PDF]
21 Jul 2008: Existence of Share Purchase Plan [PDF]
21 Jul 2008: Appendix 3B [PDF]
09 Jul 2008: Clinical Wound Study [PDF]
29 Apr 2008: Appendix 4C Quarterly Report [PDF]
23 Apr 2008: Further Positive VitroGro® Preclinical Results & Clinical Trial Update [PDF]
11 Mar 2008: Change of CEO and Chief Scientist Interest [PDF]
07 Feb 2008: VitroGro® Human Clinical Trial Ethics Approval Granted [PDF]
07 Feb 2008: Appendix 4D [PDF]
31 Jan 2008: Appendix 4C Quarterly Report [PDF]
16 Jan 2008: Convertible Note Loan Facility Agreement [PDF]
14 Jan 2008: Investor Newsletter [PDF]

2007

06 Dec 2007: Appendix 3Y [PDF]
06 Dec 2007: Appendix 3Y [PDF]
29 Nov 2007: Appendix 3B [PDF]
27 Nov 2007: Appendix 3Y [PDF]
30 Oct 2007: Appendix 4C Quarterly Report [PDF]
18 Oct 2007: New VitroGro® Formulation & Patent Applications [PDF]
18 Oct 2007: Chairman's AGM Address [PDF]
18 Oct 2007: Resolutions Passed at Annual General Meeting [PDF]
18 Sep 2007: VitroGro® Clinical Trial and Commercial Update [PDF]
18 Sep 2007: Annual Report [PDF]
18 Sep 2007: Notice of Annual General Meeting/Proxy Form [PDF]
30 Aug 2007: Equity Option Plan - Options Issued to Key Researchers & Contractors [PDF]
16 Aug 2007: Investor Newsletter [PDF]
09 Aug 2007: Tissue Therapies' Full-Year Results to 30 June 2007 [PDF]
30 Jul 2007: Appendix 4C Quarterly Report [PDF]
26 Jul 2007: Strengthened Financial Position for VitroGro® Human Trials [PDF]
26 Jul 2007: Section 708 Disclosure Notice [PDF]
26 Jul 2007: Appendix 3B [PDF]
09 Jul 2007: CEO Swaps Cash Bonus for Options [PDF]
28 Jun 2007: Change of Interests of Substantial Holders [PDF]
20 Jun 2007: VitroGro Gets Positive News from Health Canada [PDF]
15 Jun 2007: Global Wound Care Expert to Advise Tissue Therapies [PDF]
23 May 2007: Awarded Australian Research Council Grant [PDF]
22 May 2007: VitroGro Human Trials to Accelerate Commercialisation [PDF]
08 May 2007: Awarded Queensland Government Grant for Stem Cell Project [PDF]
04 May 2007: Awarded $1.9 Million P3 Grant [PDF]
23 Apr 2007: Change of Substantial Holding [PDF]
20 Apr 2007: Appendix 4C Quarterly Report [PDF]
19 Apr 2007: Notice of Initial Substantial Shareholder [PDF]
17 Apr 2007: Tissue Therapies Announces Rights Issue Reporting [PDF]
10 Apr 2007: Notification of Change of Registered Office [PDF]
05 Apr 2007: Tissue Therapies Announces Completion of Rights Issue [PDF]
16 Mar 2007: Joint Development Agreement Signed with Novozymes [PDF]
14 Mar 2007: Tissue Therapies Despatches Prospectus Today [PDF]
06 Mar 2007: South African Patent Granted [PDF]
28 Feb 2007: Rights Issue Prospectus [PDF]
28 Feb 2007: Letter to Shareholders Aus NZ re Rights Issue [PDF]
08 Feb 2007: Half Yearly Report & Half Year Accounts [PDF]
30 Jan 2007: Commitments Test Entity - Second Quarter Report [PDF]
29 Jan 2007: World Wide Exclusive Laboratory Supply Contract Signed with Invitrogen [PDF]

Enquiries can be directed to investor@tissuetherapies.com.

© 2007 TISSUE THERAPIES LTD

PRIVACY POLICY | LEGAL NOTICE